From owner-freebsd-doc Fri Dec 18 00:41:36 1998 Return-Path: Received: (from majordom@localhost) by hub.freebsd.org (8.8.8/8.8.8) id AAA09361 for freebsd-doc-outgoing; Fri, 18 Dec 1998 00:41:36 -0800 (PST) (envelope-from owner-freebsd-doc@FreeBSD.ORG) Received: from nst.docomosentu.co.jp (nst.docomosentu.co.jp [210.164.206.18]) by hub.freebsd.org (8.8.8/8.8.8) with ESMTP id AAA09356 for ; Fri, 18 Dec 1998 00:41:33 -0800 (PST) (envelope-from salu8@webwork.co.jp) From: salu8@webwork.co.jp Received: from nst.docomosentu.co.jp (localhost.docomosentu.co.jp [127.0.0.1]) by nst.docomosentu.co.jp (2.5 Build 2640 (Berkeley 8.8.6)/8.8.4) with SMTP id RAA06199; Fri, 18 Dec 1998 17:39:10 +0900 Received: from 207.225.207.125 by nst.docomosentu.co.jp (InterScan E-Mail VirusWall NT) Date: Fri, 18 Dec 98 00:01:55 EST To: pol90@worldnet.att.net Subject: SNN ALERT Message-ID: <359DFE77.4AC9@erols.com> Sender: owner-freebsd-doc@FreeBSD.ORG Precedence: bulk X-Loop: FreeBSD.org December 17, 1998 StockNetworking News - Alert News Release - NuOncology Labs Inc. Symbol NLAB - OTC Bulletin Board The company has made a significant News Release regarding the validation of the company's drug, Arglabin, as a Farnesyl Transferase Inhibitor (FTI). The full text of the release can be viewed at: http://biz.yahoo.com/bw/981217/nuoncology_1.html To be removed as a SNN subscriber please put 'delete' in the subject of an empty e-mail and send it to: 4621@usa.net copyright SNN 1998 To Unsubscribe: send mail to majordomo@FreeBSD.org with "unsubscribe freebsd-doc" in the body of the message